Group One Trading’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-90,658
Closed -$10K 5725
2018
Q4
$10K Sell
90,658
-960,131
-91% -$630K ﹤0.01% 4292
2018
Q3
$1.79M Sell
1,050,789
-65,215
-6% -$117K 0.01% 1250
2018
Q2
$1.94M Buy
1,116,004
+325,557
+41% +$563K 0.02% 1161
2018
Q1
$1.45M Sell
790,447
-731,224
-48% -$1.54M 0.01% 1231
2017
Q4
$3.39M Buy
1,521,671
+414,275
+37% +$1.03M 0.02% 855
2017
Q3
$3.21M Buy
1,107,396
+273,453
+33% +$933K 0.03% 754
2017
Q2
$3.71M Buy
833,943
+251,491
+43% +$1.04M 0.04% 608
2017
Q1
$2.71M Buy
582,452
+125,975
+28% +$730K 0.03% 672
2016
Q4
$2.78M Buy
+456,477
New +$2.39M 0.03% 734

Other funds holding SGYP

Group One Trading's SGYP Position: Q1 2019 in Review

Group One Trading sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 90,658 shares — an estimated $10K sold.

Group One Trading first reported a position in SGYP in Q4 2016 and held it in 9 quarters. The position peaked at $3.71M in Q2 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • Group One Trading reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
  • Group One Trading sold 90,658 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $10K.
  • Group One Trading first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2016 and held it in 9 quarters.
  • Group One Trading's Synergy Pharmaceuticals, Inc Common Stock position peaked at $3.71M in Q2 2017.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Group One Trading's 13F filing for Q1 2019, filed 13 May 2019.